H. B. Fuller Company $FUL Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC reduced its stake in shares of H. B. Fuller Company (NYSE:FUL) by 1.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 32,522 shares of the specialty chemicals company’s stock after selling 536 shares during the period. MetLife Investment Management LLC owned approximately 0.06% of H. B. Fuller worth $1,825,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Cooke & Bieler LP acquired a new stake in shares of H. B. Fuller during the 1st quarter valued at about $36,830,000. Partners Capital Investment Group LLP grew its position in shares of H. B. Fuller by 90.3% during the 1st quarter. Partners Capital Investment Group LLP now owns 64,901 shares of the specialty chemicals company’s stock valued at $3,642,000 after acquiring an additional 30,805 shares during the period. Quantbot Technologies LP grew its position in shares of H. B. Fuller by 612.4% during the 1st quarter. Quantbot Technologies LP now owns 28,083 shares of the specialty chemicals company’s stock valued at $1,576,000 after acquiring an additional 24,141 shares during the period. Neo Ivy Capital Management acquired a new stake in shares of H. B. Fuller during the 1st quarter valued at about $990,000. Finally, Entropy Technologies LP acquired a new stake in shares of H. B. Fuller during the 1st quarter valued at about $581,000. 95.93% of the stock is owned by institutional investors and hedge funds.

H. B. Fuller Trading Down 1.7%

FUL stock opened at $59.99 on Wednesday. The company has a current ratio of 1.87, a quick ratio of 1.15 and a debt-to-equity ratio of 1.13. H. B. Fuller Company has a 12-month low of $47.56 and a 12-month high of $85.00. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of 32.42, a PEG ratio of 1.00 and a beta of 1.14. The business’s 50-day moving average is $59.92 and its 200 day moving average is $56.77.

H. B. Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, June 25th. The specialty chemicals company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.08. H. B. Fuller had a return on equity of 11.50% and a net margin of 2.92%.The company had revenue of $898.10 million for the quarter, compared to analysts’ expectations of $894.87 million. During the same period in the previous year, the firm posted $1.12 EPS. H. B. Fuller’s revenue was down 2.1% compared to the same quarter last year. H. B. Fuller has set its FY 2025 guidance at 4.100-4.30 EPS. On average, sell-side analysts anticipate that H. B. Fuller Company will post 4.07 EPS for the current fiscal year.

H. B. Fuller Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Shareholders of record on Thursday, July 31st were paid a $0.235 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend was Thursday, July 31st. H. B. Fuller’s dividend payout ratio (DPR) is 50.81%.

Insider Buying and Selling

In other H. B. Fuller news, VP Robert J. Martsching sold 9,546 shares of the firm’s stock in a transaction that occurred on Thursday, July 10th. The shares were sold at an average price of $64.30, for a total value of $613,807.80. Following the transaction, the vice president directly owned 14,980 shares of the company’s stock, valued at $963,214. This trade represents a 38.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Joao Magalhaes sold 1,099 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $56.31, for a total transaction of $61,884.69. Following the completion of the transaction, the vice president directly owned 3,285 shares in the company, valued at $184,978.35. This trade represents a 25.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,691 shares of company stock worth $734,478 over the last three months. Corporate insiders own 1.99% of the company’s stock.

Analyst Ratings Changes

FUL has been the topic of a number of analyst reports. Robert W. Baird raised their target price on H. B. Fuller from $60.00 to $75.00 and gave the company an “outperform” rating in a research report on Friday, June 27th. JPMorgan Chase & Co. raised their target price on H. B. Fuller from $50.00 to $54.00 and gave the company an “underweight” rating in a research report on Friday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $67.25.

About H. B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.